home / stock / knsl / knsl articles
Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion. BIO-key International, Inc. (NASDAQ...
Brian Haney, EVP and COO at Kinsale Cap Gr (NYSE:KNSL), reported a large insider sell on September 14, according to a new SEC filing. What Happene...
Needham cut the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $60 to $53. Needham analyst Gil Blum maintained a Buy rating. ...
News, Short Squeeze, Breakout and More Instantly...
Kinsale Capital Group Inc. Company Name:
KNSL Stock Symbol:
NASDAQ Market:
Kinsale Capital Group Inc. Website:
2024-07-11 17:15:02 ET Oppenheimer analyst issues PERFORM recommendation for KNSL on July 11, 2024 04:05PM ET. KNSL was trading at $381.83 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy, 3 - Hold...
Kinsale Capital Group, Inc. (NYSE: KNSL) announced today that it will release financial results for the second quarter of 2024 after the market closes on Thursday, July 25, 2024. The Company will host a conference call to discuss its results with analysts and investors on Friday, July 26, 202...